[HTML][HTML] Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test
TC Wright, MH Stoler, CM Behrens, A Sharma… - Gynecologic …, 2015 - Elsevier
Objectives ATHENA evaluated the cobas HPV Test as the primary screen for cervical cancer
in women≥ 25 years. This reports the 3-year end-of-study results comparing the …
in women≥ 25 years. This reports the 3-year end-of-study results comparing the …
Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test
TC Wright, MH Stoler, CM Behrens, A Sharma… - Gynecologic …, 2015 - infona.pl
ATHENA evaluated the cobas HPV Test as the primary screen for cervical cancer in
women≥ 25years. This reports the 3-year end-of-study results comparing the performance …
women≥ 25years. This reports the 3-year end-of-study results comparing the performance …
[引用][C] Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test
TC Wright, MH Stoler, CM Behrens, A Sharma… - Gynecologic …, 2015 - cir.nii.ac.jp
Primary cervical cancer screening with human papillomavirus: End of study results from the
ATHENA study using HPV as the first-line screening test | CiNii Research CiNii 国立情報学 …
ATHENA study using HPV as the first-line screening test | CiNii Research CiNii 国立情報学 …
[PDF][PDF] Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test☆
TC Wright, MH Stoler, CM Behrens, A Sharma… - 2014 - scholar.archive.org
• A negative HPV results at baseline predicts one-half the risk of CIN3+ over 3 years than a
negative cytology result.• HPV primary screening with triage using 16/18 genotyping and …
negative cytology result.• HPV primary screening with triage using 16/18 genotyping and …
[PDF][PDF] Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test☆
TC Wright, MH Stoler, CM Behrens, A Sharma… - 2014 - academia.edu
• A negative HPV results at baseline predicts one-half the risk of CIN3+ over 3 years than a
negative cytology result.• HPV primary screening with triage using 16/18 genotyping and …
negative cytology result.• HPV primary screening with triage using 16/18 genotyping and …
[PDF][PDF] Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test☆
TC Wright, MH Stoler, CM Behrens, A Sharma… - 2014 - newswise.com
• A negative HPV results at baseline predicts one-half the risk of CIN3+ over 3 years than a
negative cytology result.• HPV primary screening with triage using 16/18 genotyping and …
negative cytology result.• HPV primary screening with triage using 16/18 genotyping and …
Primary Cervical Cancer Screening With Human Papillomavirus: End of Study Results From the ATHENA Study Using HPV as the First-Line Screening Test
TC Wright, MH Stoler, CM Behrens… - Obstetrical & …, 2015 - journals.lww.com
Human papillomavirus (HPV) testing has been used in the United States as a follow-up test
for women with a cytology finding of atypical squamous cells of undetermined significance …
for women with a cytology finding of atypical squamous cells of undetermined significance …
[PDF][PDF] Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test☆
TC Wright, MH Stoler, CM Behrens… - Gynecologic …, 2015 - cyberleninka.org
• A negative HPV results at baseline predicts one-half the risk of CIN3+ over 3 years than a
negative cytology result.• HPV primary screening with triage using 16/18 genotyping and …
negative cytology result.• HPV primary screening with triage using 16/18 genotyping and …
Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test.
TC Wright, MH Stoler, CM Behrens, A Sharma… - 2015 - cabidigitallibrary.org
Objectives: ATHENA evaluated the cobas HPV Test as the primary screen for cervical
cancer in women≥ 25 years. This reports the 3-year end-of-study results comparing the …
cancer in women≥ 25 years. This reports the 3-year end-of-study results comparing the …
Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test
TC Wright, MH Stoler, CM Behrens… - Gynecologic …, 2015 - pubmed.ncbi.nlm.nih.gov
Objectives ATHENA evaluated the cobas HPV Test as the primary screen for cervical cancer
in women≥ 25years. This reports the 3-year end-of-study results comparing the …
in women≥ 25years. This reports the 3-year end-of-study results comparing the …